Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 3056 participants.
Also called NCT02494895
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 3,056 participants
- Sponsor
- Registry
-
NCT02494895
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02494895. Randomized; no masking; primary purpose treatment. Start 2015-08-01 (actual); primary completion 2023-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Ticagrelor monotherapy
- Intervention (Drug)
- Ticagrelor with Aspirin DAPT(dual antiplatelet treatment)
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct02494895- Content hash
c6558143f322342fa81443a3a151f3834fe3672b58b97ced9a8937b3a306c648